vial of retatrutide Bulk Retatrutide-RUO 20MG 10 x 20MG Vials Demand for Unapproved Weight-Loss Drug

Many more GLP-1 drugs are in development

Aesthetic Surg J

PMID 24112036

Rajesh Aggarwal, an obesity doctor and founding CEO of twenty30 health a technology platform for individuals with obesity and metabolic disease described the world of GLP-1 compounding as a Wild West preying on desperate individuals. Dr

Research suggests GIP activation improves insulin sensitivity in adipose tissue, may contribute to central nervous system appetite regulation beyond what GLP-1 provides, and appears to reduce some of the gastrointestinal side effects associated with GLP-1 agonism alone

By targeting the brains appetite centers, retatrutide reduces hunger and increases feelings of fullness, leading to decreased calorie intake